Antitumor combination combining ave8062 and docetaxel.

• 收藏
• 分享

专利权人:

SANOFI

发明人:

MICHÈLE BESENVAL

申请号：

BRPI0923349

公开号：

BRPI0923349A2

申请日:

2009.12.10

申请国别(地区):

BR

年份:

2015

代理人:

摘要：

The invention relates to a sequential antitumor combination of AVE8062, or a salt thereof, and docetaxel, characterized in that AVE8062 is administered to a patient in a dose of 10 to 50 mg/m2, and then, on a different day of the week, preferably after a 24-hour interval, docetaxel is administered in a dose of 50 to 120 mg/m2.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/